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ASSESSMENT PROCEDURES
Reliability and responsiveness of measures of pain in people with osteoarthritis of
the knee: a psychometric evaluation
Katie V. Turner, Bryan M. Moreton, David A. Walsh andNadina B. Lincoln
Arthritis Research UK Pain Centre, University of Nottingham, Nottingham, UK
ABSTRACT
Purpose: To examine the fit between data from the Short Form McGill Pain Questionnaire (SF-MPQ-2) and
the Rasch model, and to explore the reliability and internal responsiveness of measures of pain in people
with knee osteoarthritis. Methods: Participants with knee osteoarthritis completed the SF-MPQ-2,
Intermittent and Constant Osteoarthritis Pain questionnaire (ICOAP) and painDETECT. Participants were
sent the same questionnaires 3 and 6 months later. Results: Fit to the Rasch model was not achieved for
the SF-MPQ-2 Total scale. The Continuous subscale yielded adequate fit statistics after splitting item 10 on
uniform DIF for gender, and removing item 9. The Intermittent subscale fit the Rasch model after rescoring
items. The Neuropathic subscale had relatively good fit to the model. Test–retest reliability was satisfactory
for most scales using both original and Rasch scoring ranging from fair to substantial. Effect sizes ranged
from 0.13 to 1.79 indicating good internal responsiveness for most scales. Conclusions: These findings sup-
port the use of ICOAP subscales as reliable and responsive measure of pain in people with knee osteoarth-
ritis. The MPQ-SF-2 subscales found to be acceptable alternatives.
 IMPLICATIONS FOR REHABILITATION
 The McGill Pain Questionnaire short version 2 is not a unidimensional scale in people with knee osteo-
arthritis, whereas three of the subscales are unidimensional.
 The McGill Pain Questionnaire short version 2 Affective subscale does not have good measurement
properties for people with knee osteoarthritis.
 The McGill Pain Questionnaire short version 2 and the Intermittent and Constant Osteoarthritis Pain
scales can be used to assess change over time.
 The painDETECT performs better as a screening measure than as an outcome measure.
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Introduction
Measures of pain have been developed to assess pain characteris-
tics and severity in people with osteoarthritis (OA). Pain question-
naires aim to measure the overall severity of pain or the severity
or nature of specific dimensions of the pain experience. Overall
pain severity is quantified by combining responses to questions
that target specific dimension of the pain experience. Ideally ques-
tionnaires should demonstrate unidimensionality and combining
several dimensions into a single scale can affect the validity of the
scale.[1] The scale may not measure the single construct intended
but be an amalgamation of measures of several constructs.
The Intermittent and Constant Osteoarthritis Pain (ICOAP) ques-
tionnaire was developed to assess two kinds of OA pain [2] based on
the aspects of pain that were identified as distinct and important by
focus groups of people with OA.[3] Constant pain was characterized
as a continuous aching sensation, and intermittent pain was
described as being severe but transient. It has been proposed that a
total score may be a useful measure of overall pain severity in OA.[2]
Moreton et al. [4] reported that the Constant and Intermittent sub-
scales of the ICOAP fit the Rasch model following removal of a few
items, but raised some concerns over the external validity of the
Total score and recommended that the Constant and Intermittent
subscales were used rather than the Total scale. Davis et al. [5] dem-
onstrated the responsiveness of the ICOAP to the effect of surgery in
people receiving total hip or total knee replacement. Singh et al. [6]
demonstrated test–retest reliability in patients with a diagnosis of
OA at baseline and 2-week follow-up, and found that the ICOAP was
more reliable in patients with hip compared to knee OA.
The Revised Short Form McGill Pain Questionnaire Short Form
(revised SF-MPQ) [7] assesses the quality of the pain experience,
based on descriptive characteristics. It assesses both neuropathic
and non-neuropathic pain in four dimensions, continuous, intermit-
tent, neuropathic and affective descriptors. Strand et al. [8] investi-
gated the reliability and responsiveness of the Norwegian version
of the SF-MPQ (NSF-MPQ) in patients with musculoskeletal and
rheumatic pain and found that test–retest reliability and respon-
siveness of the NSF-MPQ were satisfactory but reported that the
measurement properties varied between groups of patients with
pain. Grafton et al. [9] reported good reliability for the McGill Pain
Questionnaire in people with osteoarthritis of the hip and knee,
but did not examine responsiveness.
The painDETECT [10] was developed to help guide diagnosis
of neuropathic pain but has also been used to measure
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neuropathic-like symptoms.[11,12] The painDETECT classifies peo-
ple into groups based on a summative score from nine items.
Moreton et al. [13] conducted Rasch analysis on scores from peo-
ple with osteoarthritis of the knee and showed that the
painDETECT displayed good fit to the Rasch model and was rela-
tively well targeted to the sample.
If measures are to be used to assess the effectiveness of inter-
ventions, they need to be reliable over time if no change has
occurred, yet sensitive to the effects of the intervention. These
attributes need to be checked in the target population to optimize
the ability to use the scales as outcome measures. Rasch analysis
has been used to improve the measurement properties of com-
monly used measures of pain.[4,13] One potential advantage of
Rasch converted scores is that they are expected to increase the
ability to detect change over time.
The aims of the study were:
1. To examine the fit between data obtained from the Short
Form McGill Pain Questionnaire version 2 (SF-MPQ-2) and the
Rasch model.
2. To measure the reliability and internal responsiveness of
Rasch analyzed versions of measures of pain in comparison
with standard versions in people with knee osteoarthritis.
Methods
Participants were recruited from a group of patients who took part
in previous studies at the University of Nottingham and agreed to
be contacted about future research, clinics at Nottingham
University Hospitals, Sherwood Forest Hospitals and Derby
Hospitals NHS Trusts, General Practitioner (GP) surgeries in the
local area and from patients on the Nottinghamshire county OA
hip and knee pathway. Participants were included in the study if
they had a clinical diagnosis of knee OA, confirmed by a
Kellgren–Lawrence grade 2, and reported accompanying pain on
most days for at least the past month. Participants with another
diagnosed arthritic disorder (e.g., rheumatoid arthritis, psoriatic
arthritis, gout, fibromyalgia), people who had knee joint surgery in
the three months prior to participation, and those who could not
speak or understand English were excluded.
Informed consent was obtained from all participants and the
research was approved by Nottingham Research Ethics Committee
1 (10/H0403/70).
Participants were sent an invitation letter signed by either a
medical professional responsible for their care (e.g., consultant sur-
geon, GP, physiotherapist) or the chief investigator of the study
they previously took part in. The letter included an information
sheet, a consent form, a questionnaire set and a pre-paid reply
envelope. Some personal information was recorded from the par-
ticipants (e.g., name, address, telephone number) so that they
could be contacted. The questionnaires were presented in one of
four orders, which were randomly determined, to protect against
order effects.
For each participant, the following demographic and clinical
information were collected: age, gender, ethnicity, occupation,
education, marital status, symptom duration and any other medical
treatments they were receiving.
Participants were assessed using the ICOAP,[2] which has 11
items in two subscales. Five items address constant pain and six
items deal with intermittent pain. Responses are recorded using a
five-point scale. Ten items are phrased to assess the intensity of
pain (e.g., How intense has your constant knee pain been?). The
response options for these items are 0 (Not at all), 1 (Mildly), 2
(Moderately), 3 (Severely) or 4 (Extremely). Item 7 asks patients
about the frequency of pain (How frequently has this knee pain
that comes and goes occurred?). The response options for this
item are 0 (Never), 1 (Rarely), 2 (Sometimes), 3 (Often) or 4 (Very
often). The raw score for the Constant Pain and Intermittent Pain
subscales were transformed into Rasch scores based on the con-
versions reported by Moreton et al.[4]
The Short Form McGill Pain Questionnaire 2 (MPQ-SF-2) [14]
is comprised of 22 pain descriptors. It has four subscales (con-
tinuous pain, intermittent pain, neuropathic pain and affective
descriptors) with mean scores of the items ranging from 0 to
10. All items can also be summed to produce a mean total
pain score (range 0–10). Respondents rate the intensity of their
pain over the past week, using a numerical rating scale from 0
(none) to 10 (worst possible).
The painDETECT questionnaire [10] was designed to assess the
neuropathic elements of pain, and classifies people into groups
based on a summative score from nine-items: a neuropathic com-
ponent is unlikely (12), result is ambiguous (13–18) and neuro-
pathic component is likely (19). Most items use a 6-point scale
where higher scores are suggestive of greater intensity (where
0¼ never and 5¼ very strongly). Two items assess the temporal
and spatial aspects of pain, using categorical response formats.
The raw painDETECT score was transformed into a Rasch score
derived from the Rasch analysis conducted and reported by
Moreton et al.[13]
As participants were provided with a lengthy set of question-
naires they were advised to complete as many as they felt able to.
Names and telephone numbers were requested so that it was pos-
sible to contact participants if required. Some demographic infor-
mation (age, gender) was also collected. The questionnaires were
completed at home and returned to the researchers by pre-paid
envelope. Non-respondents were sent one reminder letter after
3 weeks.
Participants were invited to indicate on their consent form their
willingness to complete three and six month follow-up question-
naires to examine change over time. Follow-up questionnaires
were sent to the home addresses of all those who consented.
Participants were asked if they had undergone partial or full knee
replacement surgery for one or both knees.
Five separate analyzes were carried out on the total pain scale
and the continuous pain, intermittent pain, neuropathic pain
and affective descriptor subscales of the SF-MPQ-2 using
RUMM2020.[15]
Rasch analysis assesses fit between data obtained on a scale
and the predictions of the Rasch model.[16] This was under-
taken because the model shows whether a scale meets the axi-
oms underlying additive conjoint measurement (1). To determine
whether the rating scale [17] or the partial credit formulation
[18] of the Rasch model was most appropriate, a likelihood ratio
test was performed for each analysis. If the test was not signifi-
cant (i.e., p> 0.05), then the rating scale version was adopted;
otherwise the partial credit version was used. Individual items
were inspected to see whether there was evidence of disor-
dered response thresholds.[1,16] When this was observed, the
item was rescored (i.e., collapsing appropriate adjacent response
options).
Mean and standard deviation fit residuals were calculated for
the items and the persons. The means should be close to 0 and
the standard deviations (SD) about 1. RUMM2020 creates groups,
called class intervals, based on the level of examined trait. An
item-trait interaction chi-squared was used to test whether the
hierarchical arrangement of the items was invariant across the
class intervals and p values>0.05 were considered acceptable.[16]
A person separation index (PSI) value of 0.7 indicated acceptable
internal consistency.[19]
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Each individual item and person was examined for misfit. For
items, chi-squared and Analysis of Variance (ANOVA) fit statistics
were calculated with a Bonferroni correction. Fit residuals were
also examined for items and persons. Values aboveþ2.5 or
below2.5 were considered to be misfitting the model.[16]
Differential Item Functioning (DIF) was explored for gender (men
and women) and age (<64 years, 64–71 years and>71 years).
Response dependencies between items were identified from the
residual correlation matrix. A positive correlation of0.3 was con-
sidered to be indicative of response dependency for scales with 20
items or more. Each scale was tested for a breach of unidimension-
ality [1] and Principal components analysis was performed on the
residuals and used to identify two subsets of items; those loading
positively and negatively on the first component. Person estimates
were then calculated for each subset and then a series of independ-
ent t-tests were carried out to see whether the subsets produced
significantly different estimates. Assuming that both subsets
were measuring the same unidimensional construct no more than
5% of these t-tests should be significant at a 0.05 level. A binomial
confidence interval (CI) was applied for cases that were more
than 5%.
Sample size calculations for the study were based on Rasch
analysis. Approximately 150 participants were required to have at
least 95% confidence that item calibrations were within60.5
logits.[20]
Test–retest reliability of all measures was established by com-
paring questionnaire scores obtained at baseline (T1) and 3
months (T2) in those who had not had knee surgery. This was ini-
tially calculated using raw questionnaire scores. Rasch conversion
scores derived from Moreton et al. [4] were then applied to ICOAP
Intermittent and Constant subscale scores and from Moreton et al.
[13] for the painDETECT Total score. Test–retest reliability was cal-
culated through the Intraclass Correlation Co-efficient (ICC), using a
two-way mixed model of absolute agreement.[21] Pearson’s correl-
ation coefficients were also calculated to determine the level of
linear association between questionnaire scores at T1 and T2.
Values were interpreted as follows:>0.80 was excellent, 0.61–0.80
was substantial, 0.41–0.60 was moderate, 0.21–0.40 was fair
and<0.21 was slight.[22]
For responsiveness, the Intraclass Correlation Co-efficient (ICC)
was calculated between T1 and T3 for those known to have
had knee surgery. Cohen’s d was calculated as a measure of
effect size using an online calculator (http://www.cognitiveflexi-
bility.org/effectsize), whereby the mean and standard
deviation of T1 and T3 point were included, and the value was
corrected by the correlation coefficient between the two time
points.[23]
Results
Of the 1359 people with OA invited to take part, 255 (18.8%) pro-
vided data for analysis. Participant characteristics are shown
in Table 1. Follow-up questionnaires were returned by 113 (44%)
participants. Of these, 43 (38%) had no knee replacement (NKR
Sample) and 70 (62%) had had a knee replacement within the dur-
ation of the study (KR Sample). The two groups were similar on
most demographic characteristics, however the KR sample had
experienced OA symptoms for significantly longer (mean¼ 7.4
years) than the NKR sample (mean¼ 4.9 years) (U (106)¼ 934.5,
Z¼2.79, p¼ .005).
Descriptive statistics are presented for each scale at baseline,
3 months and 6 months in Table 2.
Rasch analysis of the SF-MPQ 2
On the total scale of the SF-MPQ 2, initial fit to the model indi-
cated some misfit. Results are shown in Table 3. Item 11 misfit the
model and a number of participants also misfit the model with a
mixture of high positive and negative fit residuals. Items 2 and 3,
2 and 4, 3 and 4, 10 and 19 and 21 and 22 exhibited evidence of
response dependency. There was no evidence of differential item
functioning (DIF) for age or gender. The scale failed the test of uni-
dimensionality and all items had disordered response thresholds. A
variety of global rescoring options were explored but there was
misfit and the revised scale was mistargeted. Therefore, the sub-
scales were examined.
On the Continuous subscale, the likelihood ratio test was sig-
nificant and so the partial credit model was used. The initial sum-
mary fit statistics indicated some misfit between data and the
model (Table 3). Items 8 and 9 misfit the model and five partici-
pants presented with high negative fit residuals. There was no evi-
dence of response dependency, but item 10 presented with
uniform DIF for gender. The subscale passed the test of unidimen-
sionality. All items had disordered thresholds. A variety of global
rescoring options were explored. Rescoring all items 01111122223
resolved the disordered thresholds and improved fit to the model.
Following this, 10 participants had high absolute fit residual values
and item 10 continued to exhibit DIF for gender. Removal of the
misfitting participants did not have a large effect on fit to the
model and so they were retained. Item 10 was split for DIF but
then item 9 exhibited misfit the model. Removal of item 9 resulted
in good fit with no remaining measurement issues. The revised
subscale was slightly mistargeted with participants, on average,
exhibiting a lower level of continuous pain than measured by
Table 1. Demographic characteristics of participants.
Baseline assessment
Follow-up assessment
Total sample n¼ 255 n (%) No knee replacement n¼ 43 n (%) Knee replacement n¼ 70 n (%)
Gender Men 108 (42.4) 19 (44.2) 33 (47.1)
Women 146 (57.3) 24 (55.8) 37 (52.9)
Missing 1 (0.4) 0 (0) 0 (0)
Ethnicity White 212 (83.1) 41 (95.3) 64 (91.4)
Non-White 11 (4.3) 3 (4.3) 1 (2.3)
Missing 26 (10.2) 0 (0) 1 (1.4)
Marital status Married 169 (66.3) 32 (74.4) 46 (65.7)
Separated/Divorced/Widowed 45 (17.7) 7 (16.3) 15 (21.4)
Single 13 (5.1) 0 (0) 4 (5.7)
Missing 28 (11.0) 4 (9.3) 5 (7.1)
Occupation Employed 57 (22.4) 11 (25.6) 19 (27.1)
Not employed 174 (68.2) 44 (62.9) 29 (67.4)
Missing 24 (9.4) 3 (7.0) 7 (10.0)
Age Mean (SD) 68.0 (9.6) 66.9 (7.8) 67.17 (10.0)
Duration of symptoms (Years) Mean (SD) 7.0 (7.3) 4.9 (5.1) 7.4 (6.4)
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items on the scale. Results are shown in Figure 1. Rasch conversion
scores are provided in Appendix.
On the Intermittent subscale, the initial summary fit statistics
indicated some misfit between data and the model (Table 3).
Items 2 and 3 misfit as did a number of participants with high
negative fit residuals. There was no response dependency or DIF
for age or gender. The scale passed the test of unidimensionality,
but all thresholds were disordered. A variety of global rescoring
options were explored. Rescoring all items 01111122223 resolved
the disordered thresholds and improved fit to the model.
Following this, nine participants misfit. However, their removal
made fit to the model slightly worse and so they were retained.
The rescored subscale was slightly mistargeted with the
participants, on average, at a lower level of intermittent pain than
measured by the items on the subscale. Results are shown in
Figures 1–3.
Rasch conversion scores are provided in Appendix.
On the Neuropathic subscale, initial fit to the model was rela-
tively good (Table 3). There were no misfitting items, but a few
participants with high negative fit residuals. There was no evi-
dence of response dependency, but item 22 presented with non-
uniform DIF for gender. The scale passed the test of unidimension-
ality, but all items had disordered response thresholds. A variety of
global rescoring options were explored. Rescoring all items
00000011111 resulted in improved fit to the model (v2¼ 15.87,
df¼ 6, p¼ 0.01). However, the subscale was now dichotomous and
there were large floor effects. Given that fit was already adequate,
it was decided to explore the effects of further analysis without
rescoring the items. Removal of the misfitting persons did not
have a substantial effect on the fit statistics and so they were
retained. As the DIF observed for item 22 was non-uniform, it was
not possible to split it for DIF. While no other items exhibited sig-
nificant DIF, examination of the item characteristics curves indi-
cated that item 17 may exhibit an opposite, albeit not significant,
pattern of DIF. Grouping these items into a subtest cancelled out
the DIF, suggesting that it would not be a problem at the test
level. Therefore, no remedial action was taken. The subscale was
slightly mistargeted with participants, on average, at a lower level
Table 3. Summary fit statistics for Rasch analysis of SF-MPQ 2.
Analysis
Mean (SD) item fit
residual
Mean (SD) person fit
residual Chi-squared (DF) p
Person
separation Index
% of significant t-tests
(95% CI)
Ideal values 0 (1) 0 (1) >0.05 0.70 <5%
MPQ total
Initial fit 0.17 (1.14) 0.38 (1.50) 89.03 (66) 0.03 0.92 10.2 (7.4–13.0)
Rescoring items 0.78 (0.91) 0.85 (1.76) 88.73 (66) 0.03 0.89 6.0 (3.2–8.8)
Remove misfitting participants 0.30 (0.97) 0.40 (1.15) 65.72 (66) 0.49 0.89 7.3 (4.2–10.4)
Subtesting items 2–3–4 and 21–22 0.12 (2.23) 0.29 (1.16) 102.29 (57) <0.001 0.88 7.0 (4.0–10.0)
Remove subtests 0.27 (1.11) 0.37 (1.03) 66.93 (51) 0.07 0.87 5.5 (2.4–8.5)
MPQ continuous
Initial fit 0.37 (0.84) 0.34 (1.20) 35.96 (18) 0.007 0.83 1.8
Rescoring items 0.29 (0.95) 0.43 (1.23) 23.05 (18) 0.19 0.78 1.8
Split item 10 for DIF and remove item 9 0.27 (0.67) 0.37 (1.07) 19.36 (18) 0.37 0.74 *
MPQ intermittent
Initial fit 0.13 (0.70) 0.49 (1.23) 40.51 (18) 0.002 0.87 3.8
Rescoring items 0.06 (1.04) 0.53 (1.17) 20.79 (18) 0.29 0.84 5.2 (2.2–8.1)
MPQ neuropathic
Initial fit 0.53 (0.74) 0.42 (1.07) 26.90 (18) .08 0.86 1.7
MPQ affective
Initial fit 0.43 (1.06) 0.48 (1.06) 25.77 (12) .01 0.85 1.1
Remove item 15 0.31 (0.34) 0.42 (0.89) 19.67 (9) .02 0.78 1.1
*Not Possible to t run the test of unidimensionality at this stage because of item split.
Table 2. Descriptive statistics for measures of pain.
No knee replacement
standard scoring
No knee replacement
Rasch converted
Knee replacement standard
scoring
Knee replacement Rasch
converted
n Mean SD n Mean SD n Mean SD n Mean SD
Baseline ICOAP C 42 32.4 23.4 42 7.4 4.1 69 57.6 23.6 69 10.1 3.7
ICOAP I 42 44.9 20.2 42 7.4 3.1 66 61.2 20.2 66 9.5 3.2
MPQ C 37 3.4 2.2 37 5.6 2.5 64 4.5 2.4 64 6.5 2.5
MPQ I 32 2.9 2.6 32 5.4 3.6 59 4.3 2.4 59 7.4 3.0
MPQ N 36 1.3 1.4 36 10.1 6.3 63 2.0 2.6 63 11.2 8.3
MPQ A 37 1.4 1.9 66 1.8 2.1
PD T 39 10.3 6.6 40 10.2 3.5 67 14.2 6.9 67 12.2 3.2
3 Months ICOAP C 40 34.8 23.1 40 6.6 3.9 66 41.8 30.5 66 7.2 5.0
ICOAP I 39 42.8 19.2 39 7.0 2.9 65 42.4 10.1 66 6.7 4.7
MPQ C 36 2.8 1.9 41 4.7 2.4 63 3.5 2.9 66 5.2 3.1
MPQ I 34 2.8 2.3 34 5.2 3.3 59 3.0 3.1 59 5.6 4.5
MPQ N 36 1.2 1.3 36 9.7 6.3 63 2.4 2.9 63 14.6 9.0
MPQ A 37 1.2 1.6 63 2.6 2.4
PD T 39 10.3 6.5 40 10.0 3.4 60 14.6 7.4 64 12.1 4.5
6 Months ICOAP C 32 30.4 22.8 33 6.0 4.1 51 19.7 23.3 51 3.5 4.0
ICOAP I 33 37.9 17.9 33 6.5 2.6 50 27.2 25.1 50 4.4 3.9
MPQ C 32 2.2 1.6 33 4.1 1.7 49 2.4 2.0 53 3.4 2.7
MPQ I 31 2.3 2.1 31 4.7 3.1 50 1.5 1.7 50 3.6 2.8
MPQ N 32 0.7 1.0 32 7.0 5.9 48 1.2 2.0 48 10.1 6.4
MPQ A 32 1.0 1.8 50 1.4 1.5
PD T 30 9.3 4.5 31 9.9 2.5 37 12.5 6.4 50 10.8 3.1
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Figure 1. Person item thresholds for subscales of the McGill pain questionnaire – continuous scale.
Figure 2. Person item thresholds for subscales of the McGill pain questionnaire – intermittent scale.
Figure 3. Person item thresholds for subscales of the McGill pain questionnaire – neuropathic scale.
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of neuropathic pain than measured by items on the subscale.
Results are shown in Figure 1. Rasch conversion scores are pro-
vided in Appendix.
On the Affective subscale, the initial summary fit statistics indi-
cated some misfit between data and the model (Table 3). Item 15
misfit and five participants had high negative fit residuals. There
was no evidence of response dependency or DIF for age or gen-
der. The scale passed the test of unidimensionality, but all items
had disordered response thresholds. A variety of global rescoring
options were explored. None of the rescoring options resolved all
of the disordered response thresholds and improved overall fit.
Therefore, the items were left with disordered thresholds. Removal
of the misfitting participants also did not improve fit to the model
and so they were retained. Therefore, conversion values are not
provided.
Test–retest reliability
Test–retest reliability was assessed between baseline and 3 months
later in participants who did not undergo knee replacement sur-
gery. Based on the ICC on the standard scoring, the test–retest
reliability of measures for the total sample ranged from fair to
moderate. Results are shown in Table 4. The ICOAP Constant sub-
scale and MPQ Intermittent subscale had substantial test–retest
reliability and the MPQ Neuropathic subscale fair reliability.
Rasch conversion scores were applied to all data, apart from
the MPQ Affective scale as this scale did not satisfactorily fit the
Rasch model. Descriptive statistics for the Rasch converted scores
are presented in Table 2. Overall, ICC values were similar to those
of the standard scoring (Table 4) and ranged from fair to moder-
ate. In terms of bivariate correlations, most correlation coefficients
were lower when Rasch conversions were applied (Table 4).
Responsiveness to change
Responsiveness to change was evaluated between baseline and 6
months later in those who had had a knee replacement. When
using the standard scoring, ICC’s ranged from 0.27 to 0.70
(Table 5), Bivariate correlations ranged from 0.22 to 0.61.
Using Rasch transformed scores, the ICCs and bivariate correlations
were similar (ICC 0.24–0.63, r¼ 0.24–0.63). Effect sizes between T1
and T3 ranged from small (dz¼ 0.09) to large (dz¼ 1.69).
Discussion
Rasch analysis of the MPQ-SF2 did not support the unidimension-
ality of the total scale but did support the unidimensionality of
three of the four subscales; continuous, intermittent and neuro-
pathic. The affective subscale did not fit the Rasch model, and
these items could probably be removed, as they do not assess a
unidimensional construct. Alternative measures of the affective
components of pain should be used. These results support the use
of the three subscales of the MPQ-SF but not the total score. The
need to separate intermittent and continuous components of pain
is consistent with previous Rasch analysis of the OCOAP,[4] which
also found that intermittent and constant pain needed to be
assessed on separate scales. It also highlights that there may be
differences in the mechanisms of pain involved, and the use of
total scores on measures, such as the MPQ-SF2 and ICOAP, may
mask important differences.
In addition, there were problems with disordered response
thresholds on the MPQ-SF2 which required rescoring of items by
collapsing response categories. The ten numerical responses were
intended to increase responsiveness of the scale for use as an out-
come measure in clinical trials,[14] but these results suggest that
the ten response categories could be reduced to three. The
response categories used in earlier versions [7–9] may be better.
Test–retest reliability of the pain measures varied. The ICOAP
constant subscale and the MPQ-SF-2 continuous subscale were the
most reliable over time in people who had not had knee replace-
ment. However, it is not appropriate to mix subscales from differ-
ent questionnaires. Based on this, the ICOAP had higher
test–retest reliability than the MPQ-SF-2, especially when using the
Rasch converted scores. The results also support previous research
on the MPQ-SF2,[8,9] which found acceptable reliability over time.
Responsiveness to change following knee surgery was good
with moderate to large effect sizes. The ICOAP was more respon-
sive than the MPQ-SF-2, with larger effect sizes. The lowest effect
Table 4. Test–retest reliability of measures of pain in participants who did not have knee surgery.
Standard scoring Rasch converted scoring
ICC n ICC 95% CI P n r p n ICC 95% CI n r p
ICOAP C 29 0.61 0.41–0.77 <0.001 39 0.84 <0.001 30 0.60 0.40–0.77 39 0.81 <0.001
ICOAP I 29 0.36 0.12–0.59 0.001 38 0.63 <0.001 29 0.33 0.10–.57 38 0.61 <0.001
MPQ C 26 0.50 0.27–0.71 <0.001 33 0.65 <0.001 29 0.35 0.13–0.58 36 0.61 <0.001
MPQ I 24 0.67 0.47–0.83 <0.001 29 0.71 <0.001 24 0.60 0.38–0.79 29 0.53 0.002
MPQ N 26 0.38 0.15–0.62 <0.001 33 0.43 0.01 28 0.39 0.16–0.61 36 0.47 0.006
MPQ A 28 0.52 0.31–0.72 <0.001 35 0.80 <0.001
PD T 27 0.58 0.36–0.76 <0.001 37 0.71 <0.001 30 0.57 0.37–0.74 39 0.63 <0.001
Table 5. Responsiveness to change in measures of pain for participants who had knee replacement surgery.
Knee replacement standard scoring Knee replacement Rasch converted scoring
ICC n ICC 95% CI p n
r T1 with
T3 p
Effect
size n ICC 95% CI p n
r T1 with
T3 p
Effect
size
ICOAP C 46 0.33 0.07–0.56 <0.001 50 0.52 <0.001 1.59 46 0.35 0.07–0.59 <0.001 50 0.54 <0.001 1.69
ICOAP I 45 0.32 0.09–0.22 <0.001 50 0.33 0.02 1.30 46 0.37 0.11–0.58 <0.001 50 0.39 0.006 1.29
MPQ C 43 0.42 0.17–0.63 <0.001 47 0.48 0.001 1.08 45 0.38 0.15–0.59 <0.001 47 0.44 <0.001 1.27
MPQ I 37 0.27 0.07–0.49 <0.001 42 0.22 0.16 1.12 37 0.31 0.10–0.52 <0.001 42 0.24 0.03 1.02
MPQ N 39 0.44 0.25–0.62 <0.001 44 0.29 0.06 0.15 39 0.35 0.16–0.55 <0.001 44 0.27 0.02 0.09
MPQ A 43 0.52 0.30–0.70 <0.001 48 0.61 <0.001 0.78
PD T 33 0.70 0.53–0.83 <0.001 36 0.61 <0.001 0.29 43 0.63 0.45–0.77 <0.001 47 0.63 <0.001 0.56
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sizes were in the MPQ-SF-2 Neuropathic scale and painDETECT.
This might reflect a predominant benefit of knee replacement on
nociceptive rather than neuropathic pain mechanisms, as indicated
by improvements in constant/continuous and intermittent pain
rather symptoms that are more characteristic of neuropathic pain.
Further research should elucidate whether painDETECT is a useful
outcome measure for interventions targeting OA pain mechanisms
that overlap with those mediating neuropathic pain. The respon-
siveness of the affective scale of the MPQ-SF2 was high, which is
in contrast to a previous study [8] which found the affective scale
was least responsive to change.
There are limitations to the study. The data on the MPQ-SF-2
was collected as part of an evaluation of a large set of question-
naires and therefore was not completed by all those invited to
complete the questionnaires. However, the sample was large and
obtained from a range of sources and is probably representative
of those with OA knee. The retest questionnaires were only com-
pleted by 44% of those who were assessed at baseline. Although
the demographic characteristics of those who completed initial
assessment and those who completed the retest are similar
(Table 1), they may have differed on characteristics which were
not assessed. The retest interval was quite long and although par-
ticipants were known not to have had surgery in this interval they
may have had changes to medical management, which could have
changed their scores. The reported test–retest reliability estimates
may therefore be an underestimate of the stability of the scales
over time. The responsiveness was assessed in people who had
had knee surgery but did not include those who had received
other treatments that may have changed their pain scores.
However, responsiveness for constant/continuous and intermittent
subscales was shown to be good, although greater responsiveness
of neuropathic scales to other kinds of treatment cannot be
excluded
Overall the study supports the use of the ICOAP as a reliable
and responsive measure of pain in people with osteoarthritis of
the knee, comprising two unidimensional scales. The MPQ-SF-2
was found to be an acceptable alternative, but the affective items
did not form a unidimensional scale. Use of painDETECT to assess
neuropathic qualities of OA pain merits further study, but alterna-
tive measures should be used to address affective components of
OA pain. Rasch transformations improved the internal validity of
questionnaires, despite having little impact on repeatability or
responsiveness to change.
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Appendix
Conversion of SF-MPQ2 scales to Rasch scores
SF-MPQ 2 Continuous subscale conversion Include scores from
only items 1, 5–6, 8, 9 and 10. Rescore all items as follows: 0¼ 0,
1¼ 1, 2¼ 1, 3¼ 1, 4¼ 1, 5¼ 1, 6¼ 2, 7¼ 2, 8¼ 2, 9¼ 2 and 10¼ 3.
Discount scores for item 9. Sum the scores for males and females
separately to produce a value from 0 to 15. Look up the score in
the table below and match it to the corresponding ‘‘Rasch’’ score.
SF-MPQ 2 intermittent subscale conversion Include scores from
only items 2–4, 11, 16 and 18. Rescore all items as follows: 0¼ 0,
1¼ 1, 2¼ 1, 3¼ 1, 4¼ 1, 5¼ 1, 6¼ 2, 7¼ 2, 8¼ 2, 9¼ 2 and 10¼ 3.
Sum the scores from the items to produce a score from 0 to 18.
Look up the score in the table below and match it to the corre-
sponding ‘‘Rasch’’ score.
SF-MPQ 2 neuropathic subscale conversion Include scores from
only items 7, 17, 19–22. Sum the scores from the items to produce
a score from 0 to 60. Look up the score in the table below and
match it to the corresponding ‘‘Rasch’’ score.
Standard score Women’s ‘‘Rasch’’ score Men’s ‘‘Rasch’’ score
0 0 0
1 1.92 1.96
2 3.29 3.32
3 4.30 4.25
4 5.08 5.00
5 5.78 5.63
6 6.43 6.23
7 7.05 6.82
8 7.70 7.44
9 8.38 8.12
10 9.13 8.91
11 9.97 9.82
12 10.92 10.84
13 11.97 11.96
14 13.32 13.33
15 15 15
Standard score ‘‘Rasch’’ score
0 0
1 1.85
2 3.24
3 4.28
4 5.13
5 5.90
6 6.60
7 7.26
8 7.91
9 8.55
10 9.23
11 9.98
12 10.80
13 11.69
14 12.67
15 13.69
16 14.80
17 16.22
18 18
Standard score ‘‘Rasch’’ score
0 0
1 5.16
2 7.90
3 9.42
4 10.33
5 11.24
6 11.85
7 12.46
8 12.91
9 13.37
10 13.82
11 14.13
12 14.58
13 14.89
14 15.19
15 15.65
16 15.95
17 16.25
18 16.56
19 16.71
20 17.01
21 17.32
22 17.62
23 17.92
24 18.23
25 18.53
26 18.68
27 18.99
28 19.29
29 19.59
30 19.90
31 20.20
32 20.35
33 20.66
34 20.96
35 21.27
36 21.57
37 21.87
38 22.18
39 22.63
40 22.94
41 23.24
42 23.70
43 24.00
44 24.46
45 24.91
46 25.37
47 25.97
48 26.58
49 27.19
50 27.95
51 28.86
52 29.77
53 31.14
54 32.51
55 34.33
56 36.61
57 39.34
58 43.29
59 49.67
60 60
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